The treatment landscape for type 2 diabetes and obesity has changed dramatically with the rise of GLP-1 therapies. If you’ve been following medications like Ozempic, Wegovy, or Zepbound (tirzepatide), you know they belong to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). These drugs mimic the natural hormone GLP-1, which helps regulate […]